ESN Cleer

About:

ESN Cleer is developing novel drugs for orphan Cardiomyopathies where no guideline recommended treatments exist.

Website: http://www.cleer.com.au/

Twitter/X: cleerhealth

Top Investors: WS Investments, Business.gov.au

Description:

ESN Cleer is committed to transforming the way we combat specific segments of Cardiomyopathy with its focus on repurposed drugs of orphan indications (rare diseases without specific drug treatments). Such detrimental diseases are some of the most significant causes of Heart Failure—an ailment that heavily impact on a large spectrum of the CVD population. Such diseases or syndromes carry a high mortality risk, but it also profoundly degrades the quality of life for those affected, thus underlining the importance of ESN Cleer's mission.